Sovenyr Subscribe

Signal2026-07-23

openFDA Drug Data

[FDA Approval] ILUMYA (TILDRAKIZUMAB-ASMN)

Open primary source Read on Substack

Powered by Sovenyr — cross-source signal intelligence. Figures are collected data as-dated, not investment advice.